Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)

NCT03393806 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment was terminated early before meeting target enrolment due to a high screen failure rate and the feasibility of completing the study in a timely way

Conditions

Interventions

Sponsor

GlaxoSmithKline